Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    -8.00 (-3.60%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Share Repurchase Programme - 2025

8 Apr 2025 07:02

RNS Number : 0055E
Helios Underwriting Plc
08 April 2025
Β 

Β 

8th April 2025

Helios Underwriting plc

("Helios" or the "Company")

Share Repurchase Programme - 2025

Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, announces that the Board of Directors has approved a share repurchase programme to return up to a maximum aggregate amount Β£2,000,000 to the Company's shareholders ("The Programme").

About the Programme

Β· The aggregate number of ordinary shares of 10 pence each ("Ordinary Shares") acquired by the Company pursuant to this share purchase programmes shall not exceed the maximum number of Ordinary Shares which the Company is authorised to purchase pursuant to the authority obtained at the Company's AGM to repurchase up to a maximum 7,474,514 Ordinary Shares ("General Authority") that was approved at the 2024 AGM on 28 June 2024.

Β· On 23rd July 2024 the Company announced a further repurchase of 2,466,666 ordinary shares, leaving authority to re-purchase a further 5,007,848 ordinary shares

Β· In accordance with the General Authority, the maximum price paid per Ordinary Share acquired by the Company pursuant to the Programme is to be no more than:

oΒ  105% of the average middle market closing price of an Ordinary Share on AIM for the five business days preceding the date of purchase; and

oΒ  the higher of the price of the last independent trade and the highest current independent purchase bid for Ordinary Shares on the trading venue where the purchase is carried out

Β· The Programme will commence on the date of this announcement and will continue until the earlier of either the expiration of the General Authority or until the maximum pecuniary amount has been purchased under the Programme.

Β· The purchased Ordinary Shares will be held by the Company in treasury at the Company's discretion for later reissue or cancellation. Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

Β· Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume. The maximum price paid per Ordinary Share will be no more than the net tangible asset value of the Company.

Β· The Company confirms that it currently has no unpublished inside information.

Β· The Programme will operate in accordance with and under the terms of the relevant General Authority, and within the regulatory limit on the quantity of Ordinary Shares the Company may purchase on a single day. The Programme will be conducted within the parameters of the Market Abuse Regulation 596/2014/EU and the delegated regulations made pursuant to it.

Β· However, there will be circumstance where the Company conducts share repurchases such that they exceed 25 per cent of the average daily volume in Ordinary Shares for the 20 trading days prior to the share repurchase.

Β· As at 7th April the Company's total issued share capital consisted of 78,110,302 Ordinary Shares, with one voting right per share. The Company holds 5,667,335 Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company was 72,442,947.Β 

For further information, please contact:

For further information, please contact:

Helios Underwriting plc

John Chambers - Executive Chairman 44 (0)203 965 6441

Arthur Manners - Chief Financial Officer

Deutsche Numis (Nomad and Broker)

Giles Rolls / Charles Farquhar +44 (0)20 7260 1000

FTI ConsultingΒ 

Ed Berry / Nathan Hambrook-Skinner +44 (0)7703 330 199 / +44 (0)7977 817 092

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately Β£484m of capacity for the 2025 year of account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCPKOBKFBKDBQK
Date   Source Headline
24th Dec 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20187:00 amRNSAcquisition of Lloyd's Member 54532L
6th Dec 201812:47 pmRNSCompletion of Acquisition
20th Nov 20187:00 amRNSQuarterly Syndicate Mid-Point Forecasts
15th Nov 20187:00 amRNSAcquisition of Advantage DCP Limited
12th Nov 20187:00 amRNSHelios Capacity Fund
28th Sep 20187:00 amRNSHalf-year Report
26th Sep 20189:06 amRNSAcquisition of Nomina No 505 LLP
3rd Sep 201810:20 amRNSTotal Voting Rights
30th Aug 201811:17 amRNSAcquisition of Fyshe Underwriting LLP
20th Aug 20187:00 amRNSQuarterly Syndicate Mid-Point Forecasts
20th Aug 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Aug 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Aug 20187:00 amRNSProposed acquisition of Fyshe Underwriting LLP
31st Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Jun 20182:23 pmRNSResult of AGM
4th Jun 20185:16 pmRNSPosting of circular and notice of AGM
25th May 20187:00 amRNSFinal Results
22nd May 20187:00 amRNSQuarterly Syndicate Mid-Point Forecasts
22nd Mar 20187:00 amRNSQuarterly Syndicate Mid-point Forecasts
15th Jan 20182:25 pmRNSHolding(s) in Company
14th Dec 20173:35 pmRNSDirector/PDMR Shareholding
12th Dec 201712:12 pmRNSReplacement - Holding(s) in Company
12th Dec 20179:30 amRNSHolding(s) in Company
12th Dec 20177:00 amRNSDirector's Dealing
8th Dec 20177:00 amRNSDirector Appointment
1st Dec 20178:52 amRNSDirector's Dealing
29th Nov 20177:00 amRNS2018 Capacity and Trading Statement
21st Nov 20177:00 amRNSQuarterly Syndicate Mid-point Forecasts
21st Nov 20177:00 amRNSAcquisition of Chapman Underwriting Limited
29th Sep 20177:00 amRNSHalf-year Report
26th Sep 20177:00 amRNSAcquisition of Inversanda LLP
16th Aug 20177:00 amRNSDirector/PDMR Shareholding
11th Aug 20177:00 amRNSQuarterly Syndicate Mid Point Forecasts
29th Jun 20174:18 pmRNSResult of AGM and Directorate Change
9th Jun 20177:00 amRNSAcquisition of Nottus No 51 Limited
30th May 20177:00 amRNSFinal Results
23rd May 20177:00 amRNSQuarterly Syndicate Mid Point Forecasts
4th Apr 20177:00 amRNSAcquisition of Charmac
15th Mar 20177:00 amRNSQuarterly Syndicate Forecasts and Capacity Update
26th Jan 20177:00 amRNSAcquisition of Pooks
9th Jan 20174:34 pmRNSResult of General Meeting
22nd Dec 20167:00 amRNSProposed acquisition of Pooks Limited and GM
5th Dec 20167:01 amRNSUnderwriting Capacity
5th Dec 20167:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.